Study unlocks key information on major drug target for psychiatric and cognitive disorders, including schizophrenia
Tuesday, May 30, 2023 - 11:46
in Psychology & Sociology
An international study led by Monash University has, for the first time, harnessed cutting-edge technology to reveal new and unprecedented information of how a special class of drugs, known as "allosteric modulators" work at the M4 muscarinic receptor, a major target for notoriously difficult-to-treat psychiatric disorders associated with cognitive deficits, such as schizophrenia.